F2 and COVID-19: Moderate and severe forms of COVID-19 are accompanied by an increase in inflammatory biomarkers, such as CRP, procalcitonin, the neutrophil to lymphocyte ratio, and hemostasis parameters (activated partial thromboplastin time, prothrombin time, D-dimers, and fibrinogens) [29].